Joining Forces in Oncology 

Powered by Johnson & Johnson

13:45 - 14:45

Collaboration is at the heart of breakthroughs in oncology, where the stakes are high, and innovation can be life-saving. This session delves into the dynamic partnerships shaping the future of cancer care, uniting academia, biotech, pharma, and healthcare providers. Explore how alliances are accelerating progress in haematology, immunotherapy, precision oncology, and early detection technologies. Thanks to the great line-up of this session, participants will gain insights into overcoming challenges such as funding, early access, data integration, and equitable access to care. Join us to learn how joining forces can transform oncology research and treatment into impactful, patient-centered outcomes.

Andree Blaukat
CEO, Tessellate Bio 

Willem Mulder
Professor of Precision Medicine, Radboudumc & TU/e

Cheryl Zimberlin
Fund Manager, Oncode Bridge Fund

Jessica Vermeulen
Vice President Clinical R&D, Johnson & Johnson

Moderator

Powered by:
Hyphen Projects   

Let's connect:           
Book a ticket
FAQ
Contact Us
Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
          
 
 

                                    

Keep me informed Download our event app


© Copyright 2023 by Hyphen Projects